ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Alexion Pharmaceuticals Inc

Alexion Pharmaceuticals Inc (ALXN)

182.50
0.00
( 0.00% )
Updated: 20:00:00

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
182.50
Bid
183.00
Ask
185.00
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
182.50
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

ALXN Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 22.53
(374.32%)
11.84M
XLOXilio Therapeutics Inc
$ 1.6304
(155.15%)
19.28M
BDRXBiodexa Pharmaceuticals PLC
$ 1.66
(93.25%)
53.66M
OTRKOntrak Inc
$ 0.90011
(51.28%)
7.45M
AKANAkanda Corporation
$ 0.2384
(44.57%)
46.71M
PMECPrimech Holdings Ltd
$ 1.98
(-48.97%)
1.22M
NBSTWNewbury Street Acquisition Corporation
$ 0.042279
(-38.28%)
1.75k
GMDAGamida Cell Ltd
$ 0.043
(-27.36%)
30.09M
UGROUrban Gro Inc
$ 1.3799
(-23.97%)
265.95k
KODKodiak Sciences Inc
$ 5.72
(-23.22%)
495k
NKLANikola Corporation
$ 1.0194
(12.13%)
63.73M
BDRXBiodexa Pharmaceuticals PLC
$ 1.66
(93.25%)
53.66M
AKANAkanda Corporation
$ 0.2384
(44.57%)
46.71M
GMDAGamida Cell Ltd
$ 0.043
(-27.36%)
30.09M
CISSC3is Inc
$ 0.03455
(-9.55%)
28.82M

ALXN Discussion

View Posts
whytestocks whytestocks 3 years ago
JUST IN: $ALXN 2 Top Pharma Stocks to Buy Right Now

Most of us don't choose when to be sick, what illness will befall us, or what medicine we will take to recover. Thankfully, the pharmaceutical industry -- which is responsible for developing life-saving drugs -- never sleeps. While this sector has not escaped the COVID-19-induced economic c...

In case you are interested ALXN - 2 Top Pharma Stocks to Buy Right Now
πŸ‘οΈ0
whytestocks whytestocks 4 years ago
JUST IN: $ALXN Labor Day Special: 3 Deep-Discount Stocks to Buy Now

Every year since 1894, the first Monday in September has been a federally recognized holiday to "celebrate the social and economic achievements of American workers," according to the U.S. Department of Labor.  However, Labor Day has taken on a completely different feel in 2020. The coronav...

In case you are interested ALXN - Labor Day Special: 3 Deep-Discount Stocks to Buy Now
πŸ‘οΈ0
Renee Renee 4 years ago
ALXN SEC Admin. Proceeding: Cease and Desist Order:

https://www.sec.gov/litigation/admin/2020/34-89214.pdf
πŸ‘οΈ0
Inthe203 Inthe203 4 years ago
This Pharma is in due diligence with another one right now, so I heard. Rumor has it, Alexion is being bought.
πŸ‘οΈ0
Inthe203 Inthe203 4 years ago
ALEXION BEING SOLD TO ANOTHER PHARMA!

πŸ‘οΈ0
ADVFN_sidvicious ADVFN_sidvicious 4 years ago
1 billion in share buy back!!!! YES!
πŸ‘οΈ0
ADVFN_sidvicious ADVFN_sidvicious 4 years ago
LetterPenny, now that’s what I am talking about brother!
πŸ‘οΈ0
ADVFN_sidvicious ADVFN_sidvicious 4 years ago
LetterPenny... did you see they got approval?... hopefully that will offset the debt of the recent acquisition.
πŸ‘οΈ0
ADVFN_sidvicious ADVFN_sidvicious 4 years ago
Absolutely agree a good buy at this market price
πŸ‘οΈ0
Letterpenny Letterpenny 5 years ago
Alexion puts in stalking bid for Bertilimumab. The next big thing. Maybe they get a great deal.
πŸ‘οΈ0
stocktrademan stocktrademan 6 years ago
ALXN buy 129.83



















normal chart




log chart



πŸ‘οΈ0
Inthe203 Inthe203 7 years ago
** PENDING BUYOUT! LOAD UP FOLKS!!!!

RUMOR HAS IT that recent events of moving to Boston is due to a pending buyout! This is a strategic move to tighten the pursestrings and clean up the books!

MY SOURCES HAVE ALWAYS BEEN ACCURATE!

πŸ‘οΈ0
Inthe203 Inthe203 7 years ago
ALEXION TRIMMING THE FAT

SEE? I wasn't lying!

They are laying off 50% of their workforce, getting rid of 60% of their compounds, consolidating building and moving to Boston, all to save shareholders money.

This will initially be a HUGE hit to the PPS. We should see a record $70.00 PPS.

However, it really should bounce back immediately up to the $180's in my opinion, as this will become a more leaner company with better profit margins.

πŸ‘οΈ0
Pony up Pony up 7 years ago
Is the pipeline rich?
πŸ‘οΈ0
raff raff 7 years ago
Apparently, Soliris drug sales are increasing. But..

https://alphastreet.com/bite/4dac307

But how long can this company run on this? Given, the company has also announced that it is reducing the R&D expense for the year.
πŸ‘οΈ0
Inthe203 Inthe203 7 years ago
LAYOFFS ARE LOOMING!

Stocks will be affected - time is ticking! Dump while you can, folks!
πŸ‘οΈ0
Inthe203 Inthe203 7 years ago
CASH IN WHILE IT'S ON A HIGH!

https://seekingalpha.com/news/3273272-alexion-sputtering-kanuma-launch-write-looming

In this seeking alpha article, it clearly indicates where this company is heading. CEO Ludwig Hantson, is notorious for going into Pharmas, trimming the fat and preparing it for a buyout. That executive team that he brought in? They're all a part of the buyout team he formed in the other companies he spearheaded.

As you can see here, he's trimming the fat and I suspect he's getting rid of Alexion's metabolical area which has proven to be disastrous to the company. The article mentions Kanuma being written off, but I suspect that Strensiq will be a part of the deal as well, as both drugs has performed poorly in sales. The didn't include Strensiq as not to alarm the shareholders, but clearly that drug's sales performance is poor as well.

This means Alexion will become a one-hit-wonder again which will result in another wave of massive layoffs which I can only imagine will come before August in my opinion.

I don't even think there's anything else in the company's pipeline that's worthy at this point, is there?

The question is, who's buying them out?





πŸ‘οΈ0
Mdragonpkf Mdragonpkf 7 years ago
On the up n up!
πŸ‘οΈ0
cashmoneykid77 cashmoneykid77 7 years ago
good ill buy more
πŸ‘οΈ0
Inthe203 Inthe203 7 years ago
OH WAIT UNTIL NEXT WEEK FOLKS!

I SMELL $80 BUCKS A SHARE! COUNTDOWN BEGINS!
πŸ‘οΈ0
Mdragonpkf Mdragonpkf 7 years ago
Up up and away hey, starting next week
πŸ‘οΈ0
Inthe203 Inthe203 7 years ago
LOL!

Delusional.

You're all in for a rude awakening. Sit back and watch :)
πŸ‘οΈ0
cashmoneykid77 cashmoneykid77 7 years ago
Honestly all that I care about is the fact that Martin Shkreli is in $ALXN balls deep. Hes started numerous pharmaceutical companies and created pharmaceuticals himself. Not many people know the space better than he does, and not gonna pretend like any of my own DD will have a spec of impact. He believes the company is worth 2 to 3 times its current price. See you guys at $200.00
πŸ‘οΈ0
Dr_Thorfin Dr_Thorfin 7 years ago
I thought message boards were here to share information related to these stocks.
Guess at ALXN you guys take it too personal.
Its just a stock dude, is there a reason for your anger?
πŸ‘οΈ0
Inthe203 Inthe203 7 years ago
Sure, whatever makes you sleep at night.

So sorry your stocks are under water that you have to pump a stock :(
πŸ‘οΈ0
Dr_Thorfin Dr_Thorfin 7 years ago
LOL
most people online claiming to live in $4m homes live in their parents basement.
But okay, the bet is on
πŸ‘οΈ0
Inthe203 Inthe203 7 years ago
I will mortgage my home and bet 4M in cash that it will NOT be approved (if at all) for 3 years.

You're delusional and don't know the first thing about it. Your field is investments. You may be seated.
πŸ‘οΈ0
Dr_Thorfin Dr_Thorfin 7 years ago
Quote- "β€œI have never seen the clinical responses that I’ve observed in IgA nephropathy patients treated with OMS721,” stated Geoffrey Block, M.D., Director of Clinical Research at Denver Nephrology and Principal Investigator of the trial. β€œAll of these patients had significant renal impairment when they entered the trial and each patient dramatically improved. The improvements in these patients continued to increase after the end of treatment and persisted following completion of the trial. As an active clinical investigator, given the strength of these data, I am working hard to move this promising drug through the clinical trial process.”--
πŸ‘οΈ0
Inthe203 Inthe203 7 years ago
That's far fetched and will not happen.

This is 2 - 3 years out. That's wishful thinking and just a ploy for you to pump their stock.

Alexion is tanking on due to their own mistakes - their biggest was acquiring Synageva which is bleeding them dry.

The drug you mentioned, if approved will be the nail on the coffin - as their drug requires a 24 hour drip at a high price tag.

Alexion's PPS should hover around 55 - 60 at the most. More layoffs are on the way, you'll see.

Fish out of water have a better chance of surviving than ALXN!

πŸ‘οΈ0
Dr_Thorfin Dr_Thorfin 7 years ago
FDA sugest them to file for BTD , due to the impressive data from phase 2
Could go real fast for OMER
πŸ‘οΈ0
Inthe203 Inthe203 7 years ago
Don't spread lies.

They are at least 2-3 years away from being approved. Just entered Phase 3.

R&D takes 10 years.

http://www.omeros.com/images/pipeline-4-6-2017-large.png




πŸ‘οΈ0
Dr_Thorfin Dr_Thorfin 7 years ago
They always say buy before leaving a sinking ship,
They know omeros has a better product , ready to be approved
πŸ‘οΈ0
Dutchdaan Dutchdaan 7 years ago
newbs sellingggg. big $$ to be made here!
πŸ‘οΈ0
Dutchdaan Dutchdaan 7 years ago
Where is Alexion Pharmaceuticals' stock going? Where will Alexion Pharmaceuticals' stock price be in 2017?

24 equities research analysts have issued 1 year target prices for Alexion Pharmaceuticals' stock. Their predictions range from $120.00 to $221.00. On average, they anticipate Alexion Pharmaceuticals' share price to reach $165.36 in the next twelve months.
πŸ‘οΈ0
Dutchdaan Dutchdaan 7 years ago
Adam Feuerstein, martin and goldman say buy its a rare opportunity plus myself. you dont get better picks.
πŸ‘οΈ0
Inthe203 Inthe203 7 years ago
With nothing good in their pipeline and their failed projection in sales, you've been sold a bill of goods!

I can't wait to check back with you in 6 months!

Have fun!
πŸ‘οΈ0
Dutchdaan Dutchdaan 7 years ago
see you at $200 in 6 months BRO
πŸ‘οΈ0
Inthe203 Inthe203 7 years ago
I know, peanut. Rare to buy into a failing company. Good for you! Congrats!
πŸ‘οΈ0
Dutchdaan Dutchdaan 7 years ago
no i just started buying last week. and will add. it is a rare opportunity.
πŸ‘οΈ0
Inthe203 Inthe203 7 years ago
Sure :)

Sorry you're under water.

πŸ‘οΈ0
Dutchdaan Dutchdaan 7 years ago
$ALXN lol green close coming!! this is going back to 200$ THIS IS THE NEXT ABBV
πŸ‘οΈ0
Inthe203 Inthe203 7 years ago
ASK THE CEO FOR A HEAD COUNT OF EMPLOYEES!

You may be surprised!

ASK THE CEO ABOUT SALES!!!

You may be surprised!

ASK THE CEO ABOUT STABILITY!!!

You may be surprised!


SELL YOUR SHARES WHILE THEY ARE STILL IN THE $90'S, FOLKS!
πŸ‘οΈ0
Inthe203 Inthe203 7 years ago
Let's focus, peanut.

The only difference between Alexion and the Titanic is that the Titanic had a band as it was sinking.

You'll see when it hits $60 PPS. You'll be wishing you sold now.
πŸ‘οΈ0
Dutchdaan Dutchdaan 7 years ago
Sure. and their batteries last for weeks right? way better then Teslas batteries and they are on the otc and nobody heared of them. it is some magical chinese investor making 10 times better batteries then tesla.. things like that dont happen irl. Technology is with with universities and the big boys etc not at some Chinese garage.
πŸ‘οΈ0
Inthe203 Inthe203 7 years ago
I made over 680K on that stock. I've done well, thanks.

*Pats you on the head*

πŸ‘οΈ0
Dutchdaan Dutchdaan 7 years ago
you just keep buying dolv.thinking it is the next tesla right? dream in son.
πŸ‘οΈ0
Dutchdaan Dutchdaan 7 years ago
yes i do.
πŸ‘οΈ0
Inthe203 Inthe203 7 years ago
You're going to put weight into the words of Martin Shkreli? LOL

If anyone reads that - they will side with me. Martin is a shyster!
πŸ‘οΈ0
Dutchdaan Dutchdaan 7 years ago
Newb martin Shkreli and goldman both say it is a buy and you think it is a sell. it is undervalued look at the numbers. and not for 1 hour. study them 1 week. strong buy
πŸ‘οΈ0
Inthe203 Inthe203 7 years ago
Stop pumping this stock.

The demise of this company was the purchase of Synageva and the bloated price they paid. They never recovered. Also the failed sales projections on their drugs.

They've been incorrect on all profit projections and their company value has been cut in half.

That being said, the stock price should be too. This stock price should be more in line with $60.00 per share.

Look at their layoffs. They are dumping people left and right. They received a huge tax break from the governor for staying in Connecticut if they create jobs, but that's not happening.

And you'll see more layoffs to come. I'd like to know how they're not reneging on the governor's agreement of creating more jobs.

You must own stock in this and now underwater.



πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock